Santa Paula power plant project lacks support
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Amgen wins one, loses one in biosimilar battle
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Thousand Oaks city manager’s firing won’t hinder economy
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →More residential units approved for Thousand Oaks Boulevard
The Thousand Oaks City Council unanimously approved on July 12 an amendment to a 2011 plan that allows the addition of 206 residential units on Thousand Oaks Boulevard. More than 26 people spoke during about two hours of debate about the amendment and 42 more wrote letters in support. The proposal will allow the development Read More →
Read More →Thousand Oaks names interim city manager
The Thousand Oaks City Council chose Assistant City Manager Andrew Powers to be interim city manager July 12. Former City Manager Scott Mitnick was fired July 7 after using his work email address to solicit donations for his sons’ high school baseball team. The council voted 5-0 to put Powers in charge while a search is conducted for a Read More →
Read More →FDA panel recommends Amgen biosimilar drug for approval
A Food and Drug Administration panel recommended an Amgen biosimilar drug for approval July 12, just days after it said the biosimilar performed like a drug it mimicked. ABP 501, made by Thousand Oaks biotech giant Amgen, replicates the effects of Humira, which is approved to treat nine conditions including rheumatoid arthritis, skin disorders and Read More →
Read More →Incubators sprouting in fits and starts
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →
Sponsored content:
2015-2016 Giving Guide
